Four out of five patients (80%) had type-2 diabetes, 23/35 (66%) took no antidiabetic drugs at baseline, 8/35 (23%) were already on oral diabetes medication, 3/35 (8.6%) were on subcutaneous multi-daily insulin injections, and one patient had combined both oral diabetes medication and basal insulin. Here, INS is linked to diabetes mellitus.